Detalhe da pesquisa
1.
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.
Rheumatology (Oxford)
; 60(12): 5583-5594, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590829
2.
Assessing disease severity in bio-naïve patients with RA on treatment with csDMARDs: insights from the Corrona Registry.
Clin Rheumatol
; 39(2): 391-400, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31637609